Pr. Alexandre LoupyAlexandre Loupy, MD PhD, is the team leader of an epidemiology research team at the National Institute of Health and Medical Research (Inserm) U970. He is also a professor of Nephrology working in the kidney transplant department of Necker Hospital. He funded the Paris Transplant Group in 2008. |
|
His research focuses on artificial intelligence and multi-organ transplantation analytics. It covers allograft transplantation, rejection, antibodies and populational sciences. Pr. Loupy defended two PhDs, one in cell biology (2011) and the other in biostatistics (2014).
Since 2015, Pr. Loupy is the head of the Paris Expertise Centre for Organ Transplantation in PARCC U970. The Paris Transplant Group is recognised in the transplant research field for high impact factor quality epidemiologic research and has changed clinical practice with wide implementation of discoveries into clinical practice. Pr. Loupy has also been appointed Professor of Nephrology and Epidemiology Kidney Transplant department at the Necker Hospital in Paris, France in 2017 and adjunct Professor at Cedars Sinaï, UCLA, California, USA, in 2020. Pr. Loupy has been appointed as Director of the Banff Scientific Committee for allograft classification in 2014 and contributes to the working groups (22 transplant centres represented worldwide), and Banff recommendations delivered to the international transplant community. Pr. Loupy is also an expert for the FDA and a member of the American Society of Transplantation. He got the Clinical science investigator award from the AST in 2017 and was awarded the National Academy of Medicine Award for his work on "Renal transplantation, anti-HLA graft rejection, and biomarker identification". Dr Loupy is also involved in the French Society of Transplantation and in the European Society of Transplantation. Pr. Loupy was Associate Editor for the Transplantation Journal from 2014 to 2018, and still is at the American Journal of Transplantation. He is also referee for the New England Journal of Medicine, Nature Medicine, The Lancet, JAMA, the American Journal of Transplantation, Kidney International, Plos Medicine and the Journal of the American Society of Nephrology. In the past years, Pr. Loupy has obtained several grants to implement cutting edge diagnostic tests at large scale. Pr Loupy is principal investigator and coordinator of international H2020 (EU-TRAIN) and national RHU (KTD-innov, iTRANSPLANT) projects. He is also PI or co-PI of several on-going clinical trials since 2018. 
|
| ||
Latest News from Alexandre Loupy
|
|
|
Publications of Alexandre Loupy
|
|